Abrysvo Vaccine
ABRYSVO (RSV) Vaccine
An appointment is needed. Call us or book online through our website or app.
Who We Vaccinate
ABRYSVO is FDA-approved to help prevent lower respiratory tract disease (LRTD) caused by RSV in adults 60 and older, and in pregnant individuals at 32 through 36 weeks gestation to help protect infants from birth through 6 months of age.
Priority groups include:
- Adults 75+
- Adults 60–74 at increased risk (chronic heart or lung disease, weakened immune system, severe obesity, diabetes, or residents of nursing homes/long-term care).
- Pregnant individuals at 32 through 36 weeks gestation.
What Is RSV?
RSV is a highly contagious virus that infects the lungs and respiratory tract. It can cause more serious illness such as bronchiolitis and pneumonia, especially in older adults, infants, and people with underlying health conditions.
